| Trial ID: | L4110 |
| Source ID: | NCT00799435
|
| Associated Drug: |
Exenatide
|
| Title: |
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00799435/results
|
| Conditions: |
Diabetes Mellitus, Type 2|Heart Failure, Diastolic
|
| Interventions: |
DRUG: Exenatide
|
| Outcome Measures: |
Primary: Change in Aortic Stiffness, as Measured by the Change in the Mean Aortic Pulse Wave Velocity, Measured at Week 12 | Secondary: Changes in Left Ventricular Diastolic Stiffness, Serum Levels of Advanced Glycation End Products, Serum Biomarkers of Collagen Synthesis, and Serum Levels of Brain Natriuretic Peptide, Given the cessation of trials, the biomarkers analyses and diastolic function measures were not performed., Measured at Week 12
|
| Sponsor/Collaborators: |
Sponsor: Baylor College of Medicine | Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
2
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-07
|
| Completion Date: |
2012-04
|
| Results First Posted: |
2017-09-21
|
| Last Update Posted: |
2020-09-04
|
| Locations: |
Baylor College of Medicine, Houston, Texas, 77030, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00799435
|
